Cargando…

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease

Since their appearance in the armamentarium for inflammatory bowel disease (IBD) more than a decade ago, antitumor necrosis factor (TNF) inhibitors have demonstrated beneficial activity in induction and maintenance of clinical remission, mucosal healing, improvement in quality of life, and reduction...

Descripción completa

Detalles Bibliográficos
Autores principales:	Altwegg, Romain, Vincent, Thierry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976924/ https://www.ncbi.nlm.nih.gov/pubmed/24757282 http://dx.doi.org/10.1155/2014/172821

Ejemplares similares

Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease
por: Tighe, Donal, et al.
Publicado: (2017)

Strategies for Immunomonitoring after Vaccination and during Infection
por: Adam, Lucille, et al.
Publicado: (2021)

Development of the automated immunomonitoring system
por: Osawa, Ryuji, et al.
Publicado: (2014)

From Immunomonitoring to Immune Intervention
por: Toubert, Antoine, et al.
Publicado: (2015)

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021)

In vitro immunomonitoring of insect venom-allergic patients on immunotherapy
por: Cifuentes, Liliana, et al.
Publicado: (2014)

Longitudinal immunomonitoring following Tocilizumab in rheumatoid arthritis
por: Pers, Yves-Marie, et al.
Publicado: (2011)

Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy
por: Dahmus, Jessica, et al.
Publicado: (2020)

Anti-TNF Withdrawal in Inflammatory Bowel Disease
por: Torres, Joana, et al.
Publicado: (2016)

A guide to preparation of patients with inflammatory bowel diseases for anti-TNF-α therapy
por: Chebli, Júlio Maria Fonseca, et al.
Publicado: (2014)

Immunomonitoring of Monocyte and Neutrophil Function in Critically Ill Patients: From Sepsis and/or Trauma to COVID-19
por: Udovicic, Ivo, et al.
Publicado: (2021)

Immunomonitoring of Human Breast Milk Cells During HCMV-Reactivation
por: Lazar, Katrin, et al.
Publicado: (2021)

Lipofection with Synthetic mRNA as a Simple Method for T-Cell Immunomonitoring
por: Jarzebska, Natalia Teresa, et al.
Publicado: (2021)

Pott’s Puffy Tumor in an Inflammatory Bowel Disease Patient on Anti-TNF Therapy
por: Miri, Ahmad, et al.
Publicado: (2021)

Recent Advances in the Optimization of Anti-TNF Treatment in Patients with Inflammatory Bowel Disease
por: Orfanoudaki, Eleni, et al.
Publicado: (2023)

Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
por: Rodriguez, Lucie, et al.
Publicado: (2020)

Anti‐TNF‐induced lupus in patients with inflammatory bowel disease
por: Picardo, Sherman, et al.
Publicado: (2019)

Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
por: Park, Jihye, et al.
Publicado: (2022)

A Review on the Use of Anti-TNF in Children and Adolescents with Inflammatory Bowel Disease
por: Aardoom, Martine A., et al.
Publicado: (2019)

Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy
por: Guillén, M. Carmen, et al.
Publicado: (2020)

Evaluation of anti-TNF therapeutic response in patients with inflammatory bowel disease: Current and novel biomarkers
por: Cui, Guanglin, et al.
Publicado: (2021)

Anti-TNF therapy for inflammatory bowel disease in patients with neurodegenerative Niemann-Pick disease Type C
por: Williams, Isabelle, et al.
Publicado: (2022)

Identification of new MUC1 epitopes using HLA-transgenic animals: implication for immunomonitoring
por: Scheikl-Gatard, Tanja, et al.
Publicado: (2017)

Articular manifestations in patients with inflammatory bowel diseases treated with anti-TNF
por: Cachen, Laurie, et al.
Publicado: (2022)

Cost-Effectiveness of Therapeutic Drug Monitoring of Anti-TNF Therapy in Inflammatory Bowel Disease: A Systematic Review
por: Marquez-Megias, Silvia, et al.
Publicado: (2022)

Multicentre Harmonisation of a Six-Colour Flow Cytometry Panel for Naïve/Memory T Cell Immunomonitoring
por: Macchia, Iole, et al.
Publicado: (2020)

Physicians Should Provide Shared Decision-Making for Anti-TNF Therapy to Inflammatory Bowel Disease Patients
por: Cha, Jae Myung, et al.
Publicado: (2017)

Favorable Effect of Anti-TNF Therapy on Insulin Sensitivity in Nonobese, Nondiabetic Patients with Inflammatory Bowel Disease
por: Paschou, Stavroula A., et al.
Publicado: (2018)

Inflammatory Bowel Disease: How Effective Is TNF-α Suppression?
por: Lo, Wing-Cheong, et al.
Publicado: (2016)

IgA Nephropathy in the Setting of Anti-TNF-α Therapy for Inflammatory Bowel Disease
por: Strobel, Thomas, et al.
Publicado: (2020)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018)

Potential Impact of Diet on Treatment Effect from Anti-TNF Drugs in Inflammatory Bowel Disease
por: Andersen, Vibeke, et al.
Publicado: (2017)

Inflammatory Bowel Disease as a Paradoxical Reaction to Anti-TNF-α Treatment—A Review
por: Mihai, Ioana Ruxandra, et al.
Publicado: (2023)

Immunomonitoring of Tacrolimus in Healthy Volunteers: The First Step from PK- to PD-Based Therapeutic Drug Monitoring?
por: in ‘t Veld, Aliede E., et al.
Publicado: (2019)

The T-Cell Response to SARS-CoV-2 Vaccination in Inflammatory Bowel Disease is Augmented with Anti-TNF Therapy
por: Li, Dalin, et al.
Publicado: (2022)

Emerging Therapies for Inflammatory Bowel Disease
por: Weisshof, Roni, et al.
Publicado: (2018)

Iron Therapy in Inflammatory Bowel Disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Antioxidant Therapy in Inflammatory Bowel Diseases
por: Dziąbowska-Grabias, Katarzyna, et al.
Publicado: (2021)

Towards standardized automated immunomonitoring: an automated ELISpot assay for safe and parallelized functionality analysis of immune cells
por: Neubauer, J. C., et al.
Publicado: (2016)

Herbal and plant therapy in patients with inflammatory bowel disease
por: Triantafyllidi, Aikaterini, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_m0dtlqv4l7id7ruqr1u7qh9t34